Back to mobile site

Dawson James Reiterates Buy Rating on Fortress Biotech (FBIO)

March 28, 2022 11:23 AM EDT Send to a Friend
Dawson James analyst Jason Kolbert reiterated a Buy rating and $24.00 price target on Fortress Biotech (NASDAQ: FBIO), following the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login